UK markets open in 52 minutes
NIKKEI 225
38,527.29 -705.51 (-1.80%) HANG SENG
16,329.61 -270.85 (-1.63%) CRUDE OIL
85.98 +0.57 (+0.67%) GOLD FUTURES
2,402.40 +19.40 (+0.81%) DOW
37,735.11 -248.13 (-0.65%) Bitcoin GBP
50,641.84 -2,056.64 (-3.90%)
Arcturus Therapeutics Holdings Inc. (ARCT)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 30.43 |
| Open | 30.57 |
| Bid | 29.28 x 100 |
| Ask | 29.44 x 100 |
| Day's range | 29.12 - 30.68 |
| 52-week range | 17.52 - 43.81 |
| Volume | |
| Avg. volume | 469,995 |
| Market cap | 788.884M |
| Beta (5Y monthly) | 2.60 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Arcturus Therapeutics Holdings Inc (ARCT) Insider Sells Shares
Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT), a biotechnology company focused on the discovery, development, and commercialization of RNA therapeutics for rare diseases and vaccines, has reported an insider transaction.
- GuruFocus.com
Arcturus Therapeutics Holdings Inc's Chief Scientific Officer & COO Pad Chivukula Sells ...
Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT), a biotechnology company focused on the discovery, development, and commercialization of RNA therapeutics for rare diseases and vaccines, has reported an insider sale according to a recent SEC filing.
- Simply Wall St.
Arcturus Therapeutics Holdings Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
Arcturus Therapeutics Holdings ( NASDAQ:ARCT ) Full Year 2023 Results Key Financial Results Revenue: US$166.8m (down...
© 2024 Yahoo. All rights reserved.